CanSino Biologics Inc.

HK$26.68As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6185Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 8Y CAGR (3.19%)
Div yield —
ROE 0.60%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.17
PE TTM 189.9
TSR TTM (42.33%)
Mkt cap HK$13.50B
ROIC (1.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$31
17.27%
19.85%
Hold 7|1|11|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.30
0.32
0.30
0.33
10.85%
21.58%
6.84%
14.13%
Revenue¥M
733.4
721.6
722.3
745.2
6.62%
2.20%
4.95%
2.36%
Peers (US$1.722B)
Cap (US$)
PE
1.816B
19.49x
1.761B
66.14x
1.667B
24.63x
1.713B
90.31x
Capital
TTM
5Y
10Y
Leveragex
0.867
0.339
0.282
EBIT/Intx
1.229
0.470
0.291
Own earn%
62.27
262.54
269.46
Sh yield%
21.36
40.89
40.15
Owners
Insiders/Inst%
4.33
84.14
Short interest%
3.11
SBC / revenue%
4.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
26–29
$1 testx
0.0
Incr. ROIC%
4